{
  "meta": {
    "trial_1_label": "placebo",
    "trial_1_text": "Amlexanox  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Placebo Placebo: 40 participants will take placebo in the form of a capsule. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Amlexanox. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Amlexanox  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry.",
    "trial_2_label": "amlexanox",
    "trial_2_text": "Amlexanox  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Amlexanox Supplement: 60 participants will take Amlexanox 2000mg in the form of capsules daily. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Amlexanox. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Amlexanox  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry."
  },
  "AE": {
    "trial_1_ae": {
      "78": 0.2124125361442566,
      "173": 0.1909080296754837,
      "87": 0.18402458727359772,
      "177": 0.18202275037765503,
      "123": 0.1545935720205307,
      "20": 0.13229840993881226,
      "189": 0.12444905191659927,
      "37": 0.11968296766281128,
      "21": 0.10991214215755463,
      "14": 0.1098494902253151,
      "17": 0.10871943086385727,
      "188": 0.10380391031503677,
      "114": 0.10023754835128784,
      "64": 0.09763341397047043,
      "46": 0.09174120426177979,
      "9": 0.09099633991718292,
      "139": 0.0891888365149498,
      "49": 0.08631154149770737,
      "2": 0.08459426462650299,
      "67": 0.08345331996679306,
      "86": 0.0826159194111824,
      "30": 0.08053983747959137,
      "85": 0.07866932451725006,
      "28": 0.07829594612121582,
      "76": 0.07795468717813492,
      "200": 0.07717767357826233,
      "68": 0.07482641935348511,
      "79": 0.07446526736021042,
      "131": 0.07420409470796585,
      "350": 0.07399328052997589,
      "104": 0.07345302402973175,
      "151": 0.07249266654253006,
      "5": 0.0710274800658226,
      "77": 0.06996315717697144,
      "29": 0.06822659820318222,
      "126": 0.06428124755620956,
      "92": 0.06301172822713852,
      "116": 0.06277170032262802,
      "193": 0.06268978118896484,
      "228": 0.062499843537807465,
      "27": 0.06211603805422783,
      "243": 0.06091229245066643,
      "61": 0.06033343821763992,
      "122": 0.05856766179203987,
      "147": 0.05835620313882828,
      "396": 0.05777870863676071,
      "276": 0.05716496333479881,
      "194": 0.05517822504043579,
      "239": 0.05496029183268547,
      "38": 0.05451822280883789,
      "180": 0.05434150621294975,
      "72": 0.054085034877061844,
      "441": 0.04958897829055786,
      "138": 0.04888661205768585,
      "269": 0.04888029396533966,
      "456": 0.048813868314027786,
      "179": 0.04850068315863609,
      "96": 0.04848409816622734,
      "204": 0.04758330062031746,
      "18": 0.04724140465259552,
      "466": 0.04699048399925232,
      "132": 0.046423010528087616,
      "144": 0.04524323716759682,
      "97": 0.043517690151929855,
      "282": 0.042059142142534256,
      "11": 0.04194142296910286,
      "75": 0.0410238578915596,
      "36": 0.04097418487071991,
      "102": 0.040885377675294876,
      "341": 0.0404069721698761,
      "355": 0.04027878865599632,
      "186": 0.04006648436188698,
      "261": 0.040039174258708954,
      "508": 0.03998357057571411,
      "101": 0.0396319143474102,
      "195": 0.03916893154382706,
      "82": 0.038627415895462036,
      "221": 0.0377497635781765,
      "69": 0.0374709889292717,
      "361": 0.037436291575431824,
      "297": 0.03731531277298927,
      "33": 0.03729226440191269,
      "1": 0.03687780722975731,
      "35": 0.03662937879562378,
      "191": 0.03544161468744278,
      "253": 0.035402920097112656,
      "98": 0.03453674167394638,
      "4": 0.0343942865729332,
      "142": 0.03404980152845383,
      "288": 0.033086977899074554,
      "31": 0.032225508242845535,
      "199": 0.032100167125463486,
      "118": 0.03201403096318245,
      "494": 0.03199395537376404,
      "268": 0.031969595700502396,
      "163": 0.03157605230808258,
      "454": 0.03143177926540375,
      "164": 0.031373973935842514,
      "397": 0.03029077872633934,
      "130": 0.029997028410434723
    },
    "trial_2_ae": {
      "78": 0.2124125361442566,
      "173": 0.1909080296754837,
      "87": 0.18402458727359772,
      "177": 0.18202275037765503,
      "123": 0.1545935720205307,
      "20": 0.13229840993881226,
      "189": 0.12444905191659927,
      "37": 0.11968296766281128,
      "21": 0.10991214215755463,
      "14": 0.1098494902253151,
      "17": 0.10871943086385727,
      "188": 0.10380391031503677,
      "114": 0.10023754835128784,
      "64": 0.09763341397047043,
      "46": 0.09174120426177979,
      "9": 0.09099633991718292,
      "139": 0.0891888365149498,
      "49": 0.08631154149770737,
      "2": 0.08459426462650299,
      "67": 0.08345331996679306,
      "86": 0.0826159194111824,
      "30": 0.08053983747959137,
      "85": 0.07866932451725006,
      "28": 0.07829594612121582,
      "76": 0.07795468717813492,
      "200": 0.07717767357826233,
      "68": 0.07482641935348511,
      "79": 0.07446526736021042,
      "131": 0.07420409470796585,
      "350": 0.07399328052997589,
      "104": 0.07345302402973175,
      "151": 0.07249266654253006,
      "5": 0.0710274800658226,
      "77": 0.06996315717697144,
      "29": 0.06822659820318222,
      "126": 0.06428124755620956,
      "92": 0.06301172822713852,
      "116": 0.06277170032262802,
      "193": 0.06268978118896484,
      "228": 0.062499843537807465,
      "27": 0.06211603805422783,
      "243": 0.06091229245066643,
      "61": 0.06033343821763992,
      "122": 0.05856766179203987,
      "147": 0.05835620313882828,
      "396": 0.05777870863676071,
      "276": 0.05716496333479881,
      "194": 0.05517822504043579,
      "239": 0.05496029183268547,
      "38": 0.05451822280883789,
      "180": 0.05434150621294975,
      "72": 0.054085034877061844,
      "441": 0.04958897829055786,
      "138": 0.04888661205768585,
      "269": 0.04888029396533966,
      "456": 0.048813868314027786,
      "179": 0.04850068315863609,
      "96": 0.04848409816622734,
      "204": 0.04758330062031746,
      "18": 0.04724140465259552,
      "466": 0.04699048399925232,
      "132": 0.046423010528087616,
      "144": 0.04524323716759682,
      "97": 0.043517690151929855,
      "282": 0.042059142142534256,
      "11": 0.04194142296910286,
      "75": 0.0410238578915596,
      "36": 0.04097418487071991,
      "102": 0.040885377675294876,
      "341": 0.0404069721698761,
      "355": 0.04027878865599632,
      "186": 0.04006648436188698,
      "261": 0.040039174258708954,
      "508": 0.03998357057571411,
      "101": 0.0396319143474102,
      "195": 0.03916893154382706,
      "82": 0.038627415895462036,
      "221": 0.0377497635781765,
      "69": 0.0374709889292717,
      "361": 0.037436291575431824,
      "297": 0.03731531277298927,
      "33": 0.03729226440191269,
      "1": 0.03687780722975731,
      "35": 0.03662937879562378,
      "191": 0.03544161468744278,
      "253": 0.035402920097112656,
      "98": 0.03453674167394638,
      "4": 0.0343942865729332,
      "142": 0.03404980152845383,
      "288": 0.033086977899074554,
      "31": 0.032225508242845535,
      "199": 0.032100167125463486,
      "118": 0.03201403096318245,
      "494": 0.03199395537376404,
      "268": 0.031969595700502396,
      "163": 0.03157605230808258,
      "454": 0.03143177926540375,
      "164": 0.031373973935842514,
      "397": 0.03029077872633934,
      "130": 0.029997028410434723
    }
  },
  "safety": {
    "trial_1_safety": 0.44212010502815247,
    "trial_2_safety": 0.44212010502815247
  },
  "efficacy": {
    "prob_trial1_gt_trial2": 0.476654589176178
  }
}